Lucia Di Marcotullio
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Functional and therapeutic effects of Glabrescione B delivery by liposomes on Hedgehog-dependent tumors.
Journal: Drug delivery and translational research
Published: July 28, 2025
Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 11, 2025
MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma.
Journal: Frontiers in oncology
Published: February 28, 2025
AMBRA1 enhances Sonic Hedgehog signaling during cerebellar development and in medulloblastoma.
Journal: Developmental cell
Published: February 13, 2025
MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancer.
Journal: Cell death and differentiation
Published: February 13, 2025
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation.
Journal: Cell death discovery
Published: October 25, 2024
New Smoothened ligands based on the purine scaffold as potential agents for treating pancreatic cancer.
Journal: Bioorganic chemistry
Published: March 28, 2024
Exploring the Potential of Anthraquinone-Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH-Dependent Tumour.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: July 13, 2023
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors.
Journal: Neoplasia (New York, N.Y.)
Published: May 31, 2023
Last Updated: 09/26/2026